Daejeon, South Korea

Sang Hyeon Yun

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Trioar, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sang Hyeon Yun. Retrieved from https://idiyas.com/inventor/sang-hyeon-yun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sang Hyeon Yun: Innovator in Drug Delivery Systems

Introduction

Sang Hyeon Yun is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of drug delivery systems, focusing on enhancing the efficacy and safety of active substances.

Latest Patents

Sang Hyeon Yun holds a patent for a "Compound comprising self-immolative group and ligand-drug conjugate comprising same." This invention provides a compound that includes a self-immolative group, allowing for the stable delivery of an active substance to a target site. The design ensures that the active substance is rapidly released at the target location, thereby increasing its efficacy while minimizing side effects in non-target areas. He has 1 patent to his name.

Career Highlights

Sang Hyeon Yun is currently associated with Trioar, Inc., where he continues to innovate in the field of drug delivery. His work is pivotal in developing new methods that enhance the effectiveness of therapeutic agents.

Collaborations

Some of his notable coworkers include Ok Ku Park and Hyun Mi Lee, who contribute to the collaborative efforts at Trioar, Inc. Their combined expertise fosters an environment of innovation and advancement in drug delivery technologies.

Conclusion

Sang Hyeon Yun's contributions to the field of drug delivery systems exemplify the importance of innovation in medicine. His work not only enhances the efficacy of treatments but also aims to reduce side effects, marking a significant advancement in pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…